Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
14,731
archived clinical trials in
Psychiatric

A Study of Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features
A Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Mifepristone vs. Placebo in the Treatment of Psychotic Symptoms in Patients With Major Depressive Disorder With Psychotic Features
Status: Enrolling
Updated:  3/8/2016
Lifetree Clinical Research
mi
from
Salt Lake City, UT
A Study of Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features
A Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Mifepristone vs. Placebo in the Treatment of Psychotic Symptoms in Patients With Major Depressive Disorder With Psychotic Features
Status: Enrolling
Updated: 3/8/2016
Lifetree Clinical Research
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Extended-Release Naltrexone for Opioid Relapse Prevention Following Release From Jail
Extended-Release Naltrexone for Opioid Relapse Prevention Following Release From Jail
Status: Enrolling
Updated:  3/8/2016
New York University School of Medicine
mi
from
New York, NY
Extended-Release Naltrexone for Opioid Relapse Prevention Following Release From Jail
Extended-Release Naltrexone for Opioid Relapse Prevention Following Release From Jail
Status: Enrolling
Updated: 3/8/2016
New York University School of Medicine
mi
from
New York, NY
Click here to add this to my saved trials
Extended-Release Naltrexone for Opioid Relapse Prevention Following Release From Jail
Extended-Release Naltrexone for Opioid Relapse Prevention Following Release From Jail
Status: Enrolling
Updated:  3/8/2016
New York City Department of Correction
mi
from
New York, NY
Extended-Release Naltrexone for Opioid Relapse Prevention Following Release From Jail
Extended-Release Naltrexone for Opioid Relapse Prevention Following Release From Jail
Status: Enrolling
Updated: 3/8/2016
New York City Department of Correction
mi
from
New York, NY
Click here to add this to my saved trials
ABT-436 for Alcohol Dependence
A Phase 2, Double-Blind, Randomized, Placebo Controlled Trial to Assess the Efficacy of ABT-436 for Alcohol Dependence
Status: Enrolling
Updated:  3/8/2016
Boston Medical Center
mi
from
Quincy, MA
ABT-436 for Alcohol Dependence
A Phase 2, Double-Blind, Randomized, Placebo Controlled Trial to Assess the Efficacy of ABT-436 for Alcohol Dependence
Status: Enrolling
Updated: 3/8/2016
Boston Medical Center
mi
from
Quincy, MA
Click here to add this to my saved trials
ABT-436 for Alcohol Dependence
A Phase 2, Double-Blind, Randomized, Placebo Controlled Trial to Assess the Efficacy of ABT-436 for Alcohol Dependence
Status: Enrolling
Updated:  3/8/2016
Johns Hopkins University School of Medicine
mi
from
Baltimore, MD
ABT-436 for Alcohol Dependence
A Phase 2, Double-Blind, Randomized, Placebo Controlled Trial to Assess the Efficacy of ABT-436 for Alcohol Dependence
Status: Enrolling
Updated: 3/8/2016
Johns Hopkins University School of Medicine
mi
from
Baltimore, MD
Click here to add this to my saved trials
ABT-436 for Alcohol Dependence
A Phase 2, Double-Blind, Randomized, Placebo Controlled Trial to Assess the Efficacy of ABT-436 for Alcohol Dependence
Status: Enrolling
Updated:  3/8/2016
Univ of Pennsylvania
mi
from
Philadelphia, PA
ABT-436 for Alcohol Dependence
A Phase 2, Double-Blind, Randomized, Placebo Controlled Trial to Assess the Efficacy of ABT-436 for Alcohol Dependence
Status: Enrolling
Updated: 3/8/2016
Univ of Pennsylvania
mi
from
Philadelphia, PA
Click here to add this to my saved trials
ABT-436 for Alcohol Dependence
A Phase 2, Double-Blind, Randomized, Placebo Controlled Trial to Assess the Efficacy of ABT-436 for Alcohol Dependence
Status: Enrolling
Updated:  3/8/2016
University of Virginia
mi
from
Charlottesville, VA
ABT-436 for Alcohol Dependence
A Phase 2, Double-Blind, Randomized, Placebo Controlled Trial to Assess the Efficacy of ABT-436 for Alcohol Dependence
Status: Enrolling
Updated: 3/8/2016
University of Virginia
mi
from
Charlottesville, VA
Click here to add this to my saved trials
ABT-436 for Alcohol Dependence
A Phase 2, Double-Blind, Randomized, Placebo Controlled Trial to Assess the Efficacy of ABT-436 for Alcohol Dependence
Status: Enrolling
Updated:  3/8/2016
Boston Med Ctr
mi
from
Boston, MA
ABT-436 for Alcohol Dependence
A Phase 2, Double-Blind, Randomized, Placebo Controlled Trial to Assess the Efficacy of ABT-436 for Alcohol Dependence
Status: Enrolling
Updated: 3/8/2016
Boston Med Ctr
mi
from
Boston, MA
Click here to add this to my saved trials
Clinical Monitoring to Facilitate Continuous Care for Substance Abusing Clients
Clinical Monitoring to Facilitate Continuous Care for Substance Abusing Clients
Status: Enrolling
Updated:  3/8/2016
Genesis Counseling Centers
mi
from
Collingswood, NJ
Clinical Monitoring to Facilitate Continuous Care for Substance Abusing Clients
Clinical Monitoring to Facilitate Continuous Care for Substance Abusing Clients
Status: Enrolling
Updated: 3/8/2016
Genesis Counseling Centers
mi
from
Collingswood, NJ
Click here to add this to my saved trials
Clinical Monitoring to Facilitate Continuous Care for Substance Abusing Clients
Clinical Monitoring to Facilitate Continuous Care for Substance Abusing Clients
Status: Enrolling
Updated:  3/8/2016
Genesis Counseling Centers, Inc.
mi
from
Marlton, NJ
Clinical Monitoring to Facilitate Continuous Care for Substance Abusing Clients
Clinical Monitoring to Facilitate Continuous Care for Substance Abusing Clients
Status: Enrolling
Updated: 3/8/2016
Genesis Counseling Centers, Inc.
mi
from
Marlton, NJ
Click here to add this to my saved trials
Clinical Monitoring to Facilitate Continuous Care for Substance Abusing Clients
Clinical Monitoring to Facilitate Continuous Care for Substance Abusing Clients
Status: Enrolling
Updated:  3/8/2016
New Journeys In Recovery
mi
from
Philadelphia, PA
Clinical Monitoring to Facilitate Continuous Care for Substance Abusing Clients
Clinical Monitoring to Facilitate Continuous Care for Substance Abusing Clients
Status: Enrolling
Updated: 3/8/2016
New Journeys In Recovery
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Clinical Monitoring to Facilitate Continuous Care for Substance Abusing Clients
Clinical Monitoring to Facilitate Continuous Care for Substance Abusing Clients
Status: Enrolling
Updated:  3/8/2016
Thomas Jefferson University IOP
mi
from
Philadelphia, PA
Clinical Monitoring to Facilitate Continuous Care for Substance Abusing Clients
Clinical Monitoring to Facilitate Continuous Care for Substance Abusing Clients
Status: Enrolling
Updated: 3/8/2016
Thomas Jefferson University IOP
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Usability Study for SOBERLINK System
Usability Study for SOBERLINK System
Status: Enrolling
Updated:  3/8/2016
Private Practice
mi
from
Fullerton, CA
Usability Study for SOBERLINK System
Usability Study for SOBERLINK System
Status: Enrolling
Updated: 3/8/2016
Private Practice
mi
from
Fullerton, CA
Click here to add this to my saved trials
Usability Study for SOBERLINK System
Usability Study for SOBERLINK System
Status: Enrolling
Updated:  3/8/2016
Addiction Alternatives
mi
from
Los Angeles, CA
Usability Study for SOBERLINK System
Usability Study for SOBERLINK System
Status: Enrolling
Updated: 3/8/2016
Addiction Alternatives
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Usability Study for SOBERLINK System
Usability Study for SOBERLINK System
Status: Enrolling
Updated:  3/8/2016
Hazelden Betty Ford
mi
from
Center City, MN
Usability Study for SOBERLINK System
Usability Study for SOBERLINK System
Status: Enrolling
Updated: 3/8/2016
Hazelden Betty Ford
mi
from
Center City, MN
Click here to add this to my saved trials
Adding Cognitive Behavioral Therapy to Drug Treatment for Social Anxiety Disorder
CBT Augmentation of Paroxetine for Social Anxiety
Status: Enrolling
Updated:  3/8/2016
New York State Psychiatric Institute Anxiety Disorders Clinic
mi
from
New York, NY
Adding Cognitive Behavioral Therapy to Drug Treatment for Social Anxiety Disorder
CBT Augmentation of Paroxetine for Social Anxiety
Status: Enrolling
Updated: 3/8/2016
New York State Psychiatric Institute Anxiety Disorders Clinic
mi
from
New York, NY
Click here to add this to my saved trials
Adding Cognitive Behavioral Therapy to Drug Treatment for Social Anxiety Disorder
CBT Augmentation of Paroxetine for Social Anxiety
Status: Enrolling
Updated:  3/8/2016
Adult Anxiety Clinic of Temple University
mi
from
Philadelphia, PA
Adding Cognitive Behavioral Therapy to Drug Treatment for Social Anxiety Disorder
CBT Augmentation of Paroxetine for Social Anxiety
Status: Enrolling
Updated: 3/8/2016
Adult Anxiety Clinic of Temple University
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Habit Reversal Training for Children and Adolescents With Trichotillomania
Habit Reversal Training for Children and Adolescents With Trichotillomania: A Controlled Trial
Status: Enrolling
Updated:  3/9/2016
Rothman Center for Pediatric Neuropsychiatry
mi
from
St. Petersburg, FL
Habit Reversal Training for Children and Adolescents With Trichotillomania
Habit Reversal Training for Children and Adolescents With Trichotillomania: A Controlled Trial
Status: Enrolling
Updated: 3/9/2016
Rothman Center for Pediatric Neuropsychiatry
mi
from
St. Petersburg, FL
Click here to add this to my saved trials
Evaluating Parenting Styles and Child Temperament Associated With Child Anxiety Disorders
Child Anxiety Disorders: Parenting and Temperament Effects
Status: Enrolling
Updated:  3/10/2016
Pediatric Anxiety Research Center/Bradley Hospital/Brown Medical School
mi
from
Providence, RI
Evaluating Parenting Styles and Child Temperament Associated With Child Anxiety Disorders
Child Anxiety Disorders: Parenting and Temperament Effects
Status: Enrolling
Updated: 3/10/2016
Pediatric Anxiety Research Center/Bradley Hospital/Brown Medical School
mi
from
Providence, RI
Click here to add this to my saved trials
Hospital Visit as Opportunity for Prevention and Engagement for HIV-Infected Drug Users
NIDA CTN Protocol 0049. Project HOPE -- Hospital Visit as Opportunity for Prevention and Engagement for HIV-Infected Drug Users
Status: Enrolling
Updated:  3/10/2016
University Hospital At University of Alabama, Birmingham (Uab)
mi
from
Birmingham, AL
Hospital Visit as Opportunity for Prevention and Engagement for HIV-Infected Drug Users
NIDA CTN Protocol 0049. Project HOPE -- Hospital Visit as Opportunity for Prevention and Engagement for HIV-Infected Drug Users
Status: Enrolling
Updated: 3/10/2016
University Hospital At University of Alabama, Birmingham (Uab)
mi
from
Birmingham, AL
Click here to add this to my saved trials
Hospital Visit as Opportunity for Prevention and Engagement for HIV-Infected Drug Users
NIDA CTN Protocol 0049. Project HOPE -- Hospital Visit as Opportunity for Prevention and Engagement for HIV-Infected Drug Users
Status: Enrolling
Updated:  3/10/2016
Jackson Memorial Hospital
mi
from
Miami, FL
Hospital Visit as Opportunity for Prevention and Engagement for HIV-Infected Drug Users
NIDA CTN Protocol 0049. Project HOPE -- Hospital Visit as Opportunity for Prevention and Engagement for HIV-Infected Drug Users
Status: Enrolling
Updated: 3/10/2016
Jackson Memorial Hospital
mi
from
Miami, FL
Click here to add this to my saved trials
Hospital Visit as Opportunity for Prevention and Engagement for HIV-Infected Drug Users
NIDA CTN Protocol 0049. Project HOPE -- Hospital Visit as Opportunity for Prevention and Engagement for HIV-Infected Drug Users
Status: Enrolling
Updated:  3/10/2016
University of Miami
mi
from
Miami, FL
Hospital Visit as Opportunity for Prevention and Engagement for HIV-Infected Drug Users
NIDA CTN Protocol 0049. Project HOPE -- Hospital Visit as Opportunity for Prevention and Engagement for HIV-Infected Drug Users
Status: Enrolling
Updated: 3/10/2016
University of Miami
mi
from
Miami, FL
Click here to add this to my saved trials
Hospital Visit as Opportunity for Prevention and Engagement for HIV-Infected Drug Users
NIDA CTN Protocol 0049. Project HOPE -- Hospital Visit as Opportunity for Prevention and Engagement for HIV-Infected Drug Users
Status: Enrolling
Updated:  3/10/2016
Grady Memorial Hospital
mi
from
Atlanta, GA
Hospital Visit as Opportunity for Prevention and Engagement for HIV-Infected Drug Users
NIDA CTN Protocol 0049. Project HOPE -- Hospital Visit as Opportunity for Prevention and Engagement for HIV-Infected Drug Users
Status: Enrolling
Updated: 3/10/2016
Grady Memorial Hospital
mi
from
Atlanta, GA
Click here to add this to my saved trials
Hospital Visit as Opportunity for Prevention and Engagement for HIV-Infected Drug Users
NIDA CTN Protocol 0049. Project HOPE -- Hospital Visit as Opportunity for Prevention and Engagement for HIV-Infected Drug Users
Status: Enrolling
Updated:  3/10/2016
Stroger Cook County Hospital/Rush University Medical Center
mi
from
Chicago, IL
Hospital Visit as Opportunity for Prevention and Engagement for HIV-Infected Drug Users
NIDA CTN Protocol 0049. Project HOPE -- Hospital Visit as Opportunity for Prevention and Engagement for HIV-Infected Drug Users
Status: Enrolling
Updated: 3/10/2016
Stroger Cook County Hospital/Rush University Medical Center
mi
from
Chicago, IL
Click here to add this to my saved trials
Hospital Visit as Opportunity for Prevention and Engagement for HIV-Infected Drug Users
NIDA CTN Protocol 0049. Project HOPE -- Hospital Visit as Opportunity for Prevention and Engagement for HIV-Infected Drug Users
Status: Enrolling
Updated:  3/10/2016
Saint Lukes-Roosevelt Hospital Center
mi
from
New York, NY
Hospital Visit as Opportunity for Prevention and Engagement for HIV-Infected Drug Users
NIDA CTN Protocol 0049. Project HOPE -- Hospital Visit as Opportunity for Prevention and Engagement for HIV-Infected Drug Users
Status: Enrolling
Updated: 3/10/2016
Saint Lukes-Roosevelt Hospital Center
mi
from
New York, NY
Click here to add this to my saved trials
Hospital Visit as Opportunity for Prevention and Engagement for HIV-Infected Drug Users
NIDA CTN Protocol 0049. Project HOPE -- Hospital Visit as Opportunity for Prevention and Engagement for HIV-Infected Drug Users
Status: Enrolling
Updated:  3/10/2016
Hahnemann University Hospital
mi
from
Philadelphia, PA
Hospital Visit as Opportunity for Prevention and Engagement for HIV-Infected Drug Users
NIDA CTN Protocol 0049. Project HOPE -- Hospital Visit as Opportunity for Prevention and Engagement for HIV-Infected Drug Users
Status: Enrolling
Updated: 3/10/2016
Hahnemann University Hospital
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Hospital Visit as Opportunity for Prevention and Engagement for HIV-Infected Drug Users
NIDA CTN Protocol 0049. Project HOPE -- Hospital Visit as Opportunity for Prevention and Engagement for HIV-Infected Drug Users
Status: Enrolling
Updated:  3/10/2016
University of Pittsburgh Medical Center (UPMC)
mi
from
Pittsburgh, PA
Hospital Visit as Opportunity for Prevention and Engagement for HIV-Infected Drug Users
NIDA CTN Protocol 0049. Project HOPE -- Hospital Visit as Opportunity for Prevention and Engagement for HIV-Infected Drug Users
Status: Enrolling
Updated: 3/10/2016
University of Pittsburgh Medical Center (UPMC)
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Hospital Visit as Opportunity for Prevention and Engagement for HIV-Infected Drug Users
NIDA CTN Protocol 0049. Project HOPE -- Hospital Visit as Opportunity for Prevention and Engagement for HIV-Infected Drug Users
Status: Enrolling
Updated:  3/10/2016
Parkland Health and Human Services
mi
from
Dallas, TX
Hospital Visit as Opportunity for Prevention and Engagement for HIV-Infected Drug Users
NIDA CTN Protocol 0049. Project HOPE -- Hospital Visit as Opportunity for Prevention and Engagement for HIV-Infected Drug Users
Status: Enrolling
Updated: 3/10/2016
Parkland Health and Human Services
mi
from
Dallas, TX
Click here to add this to my saved trials
Hospital Visit as Opportunity for Prevention and Engagement for HIV-Infected Drug Users
NIDA CTN Protocol 0049. Project HOPE -- Hospital Visit as Opportunity for Prevention and Engagement for HIV-Infected Drug Users
Status: Enrolling
Updated:  3/10/2016
Los Angeles County Harbor-UCLA Medical Center
mi
from
Torrance, CA
Hospital Visit as Opportunity for Prevention and Engagement for HIV-Infected Drug Users
NIDA CTN Protocol 0049. Project HOPE -- Hospital Visit as Opportunity for Prevention and Engagement for HIV-Infected Drug Users
Status: Enrolling
Updated: 3/10/2016
Los Angeles County Harbor-UCLA Medical Center
mi
from
Torrance, CA
Click here to add this to my saved trials
Hospital Visit as Opportunity for Prevention and Engagement for HIV-Infected Drug Users
NIDA CTN Protocol 0049. Project HOPE -- Hospital Visit as Opportunity for Prevention and Engagement for HIV-Infected Drug Users
Status: Enrolling
Updated:  3/10/2016
Johns Hopkins Hospital
mi
from
Baltimore, MD
Hospital Visit as Opportunity for Prevention and Engagement for HIV-Infected Drug Users
NIDA CTN Protocol 0049. Project HOPE -- Hospital Visit as Opportunity for Prevention and Engagement for HIV-Infected Drug Users
Status: Enrolling
Updated: 3/10/2016
Johns Hopkins Hospital
mi
from
Baltimore, MD
Click here to add this to my saved trials
Hospital Visit as Opportunity for Prevention and Engagement for HIV-Infected Drug Users
NIDA CTN Protocol 0049. Project HOPE -- Hospital Visit as Opportunity for Prevention and Engagement for HIV-Infected Drug Users
Status: Enrolling
Updated:  3/10/2016
Boston Med Ctr
mi
from
Boston, MA
Hospital Visit as Opportunity for Prevention and Engagement for HIV-Infected Drug Users
NIDA CTN Protocol 0049. Project HOPE -- Hospital Visit as Opportunity for Prevention and Engagement for HIV-Infected Drug Users
Status: Enrolling
Updated: 3/10/2016
Boston Med Ctr
mi
from
Boston, MA
Click here to add this to my saved trials
Lurasidone Pediatric Pharmacokinetics Study
A Phase 1 Open-Label, Multicenter, Single and Multiple Ascending Dose Study to Evaluate Pharmacokinetics, Safety, and Tolerability of Lurasidone in Subjects 6 to 17 Years Old With Schizophrenia Spectrum, Bipolar Spectrum, Autistic Spectrum Disorder, or Other Psychiatric Disorders
Status: Enrolling
Updated:  3/10/2016
Woodland International Research Group, Inc.
mi
from
Little Rock, AR
Lurasidone Pediatric Pharmacokinetics Study
A Phase 1 Open-Label, Multicenter, Single and Multiple Ascending Dose Study to Evaluate Pharmacokinetics, Safety, and Tolerability of Lurasidone in Subjects 6 to 17 Years Old With Schizophrenia Spectrum, Bipolar Spectrum, Autistic Spectrum Disorder, or Other Psychiatric Disorders
Status: Enrolling
Updated: 3/10/2016
Woodland International Research Group, Inc.
mi
from
Little Rock, AR
Click here to add this to my saved trials
Lurasidone Pediatric Pharmacokinetics Study
A Phase 1 Open-Label, Multicenter, Single and Multiple Ascending Dose Study to Evaluate Pharmacokinetics, Safety, and Tolerability of Lurasidone in Subjects 6 to 17 Years Old With Schizophrenia Spectrum, Bipolar Spectrum, Autistic Spectrum Disorder, or Other Psychiatric Disorders
Status: Enrolling
Updated:  3/10/2016
Woodland Northwest Research, LLC
mi
from
Springdale, AR
Lurasidone Pediatric Pharmacokinetics Study
A Phase 1 Open-Label, Multicenter, Single and Multiple Ascending Dose Study to Evaluate Pharmacokinetics, Safety, and Tolerability of Lurasidone in Subjects 6 to 17 Years Old With Schizophrenia Spectrum, Bipolar Spectrum, Autistic Spectrum Disorder, or Other Psychiatric Disorders
Status: Enrolling
Updated: 3/10/2016
Woodland Northwest Research, LLC
mi
from
Springdale, AR
Click here to add this to my saved trials
Lurasidone Pediatric Pharmacokinetics Study
A Phase 1 Open-Label, Multicenter, Single and Multiple Ascending Dose Study to Evaluate Pharmacokinetics, Safety, and Tolerability of Lurasidone in Subjects 6 to 17 Years Old With Schizophrenia Spectrum, Bipolar Spectrum, Autistic Spectrum Disorder, or Other Psychiatric Disorders
Status: Enrolling
Updated:  3/10/2016
World Wide Research Centers Inc.
mi
from
Murrietta, CA
Lurasidone Pediatric Pharmacokinetics Study
A Phase 1 Open-Label, Multicenter, Single and Multiple Ascending Dose Study to Evaluate Pharmacokinetics, Safety, and Tolerability of Lurasidone in Subjects 6 to 17 Years Old With Schizophrenia Spectrum, Bipolar Spectrum, Autistic Spectrum Disorder, or Other Psychiatric Disorders
Status: Enrolling
Updated: 3/10/2016
World Wide Research Centers Inc.
mi
from
Murrietta, CA
Click here to add this to my saved trials
Lurasidone Pediatric Pharmacokinetics Study
A Phase 1 Open-Label, Multicenter, Single and Multiple Ascending Dose Study to Evaluate Pharmacokinetics, Safety, and Tolerability of Lurasidone in Subjects 6 to 17 Years Old With Schizophrenia Spectrum, Bipolar Spectrum, Autistic Spectrum Disorder, or Other Psychiatric Disorders
Status: Enrolling
Updated:  3/10/2016
Atlanta Center for Medical Research
mi
from
Atlanta, GA
Lurasidone Pediatric Pharmacokinetics Study
A Phase 1 Open-Label, Multicenter, Single and Multiple Ascending Dose Study to Evaluate Pharmacokinetics, Safety, and Tolerability of Lurasidone in Subjects 6 to 17 Years Old With Schizophrenia Spectrum, Bipolar Spectrum, Autistic Spectrum Disorder, or Other Psychiatric Disorders
Status: Enrolling
Updated: 3/10/2016
Atlanta Center for Medical Research
mi
from
Atlanta, GA
Click here to add this to my saved trials
Lurasidone Pediatric Pharmacokinetics Study
A Phase 1 Open-Label, Multicenter, Single and Multiple Ascending Dose Study to Evaluate Pharmacokinetics, Safety, and Tolerability of Lurasidone in Subjects 6 to 17 Years Old With Schizophrenia Spectrum, Bipolar Spectrum, Autistic Spectrum Disorder, or Other Psychiatric Disorders
Status: Enrolling
Updated:  3/10/2016
University of Cincinnati, Dept. of Psychiatry & Behavioral Neuroscience
mi
from
Cincinnati, OH
Lurasidone Pediatric Pharmacokinetics Study
A Phase 1 Open-Label, Multicenter, Single and Multiple Ascending Dose Study to Evaluate Pharmacokinetics, Safety, and Tolerability of Lurasidone in Subjects 6 to 17 Years Old With Schizophrenia Spectrum, Bipolar Spectrum, Autistic Spectrum Disorder, or Other Psychiatric Disorders
Status: Enrolling
Updated: 3/10/2016
University of Cincinnati, Dept. of Psychiatry & Behavioral Neuroscience
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Lurasidone Pediatric Pharmacokinetics Study
A Phase 1 Open-Label, Multicenter, Single and Multiple Ascending Dose Study to Evaluate Pharmacokinetics, Safety, and Tolerability of Lurasidone in Subjects 6 to 17 Years Old With Schizophrenia Spectrum, Bipolar Spectrum, Autistic Spectrum Disorder, or Other Psychiatric Disorders
Status: Enrolling
Updated:  3/10/2016
CRI Worldwide, LLC
mi
from
Philadelphia, PA
Lurasidone Pediatric Pharmacokinetics Study
A Phase 1 Open-Label, Multicenter, Single and Multiple Ascending Dose Study to Evaluate Pharmacokinetics, Safety, and Tolerability of Lurasidone in Subjects 6 to 17 Years Old With Schizophrenia Spectrum, Bipolar Spectrum, Autistic Spectrum Disorder, or Other Psychiatric Disorders
Status: Enrolling
Updated: 3/10/2016
CRI Worldwide, LLC
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Lurasidone Pediatric Pharmacokinetics Study
A Phase 1 Open-Label, Multicenter, Single and Multiple Ascending Dose Study to Evaluate Pharmacokinetics, Safety, and Tolerability of Lurasidone in Subjects 6 to 17 Years Old With Schizophrenia Spectrum, Bipolar Spectrum, Autistic Spectrum Disorder, or Other Psychiatric Disorders
Status: Enrolling
Updated:  3/10/2016
Aspen Clinical Research, LLC
mi
from
Orem, UT
Lurasidone Pediatric Pharmacokinetics Study
A Phase 1 Open-Label, Multicenter, Single and Multiple Ascending Dose Study to Evaluate Pharmacokinetics, Safety, and Tolerability of Lurasidone in Subjects 6 to 17 Years Old With Schizophrenia Spectrum, Bipolar Spectrum, Autistic Spectrum Disorder, or Other Psychiatric Disorders
Status: Enrolling
Updated: 3/10/2016
Aspen Clinical Research, LLC
mi
from
Orem, UT
Click here to add this to my saved trials
Lurasidone Pediatric Pharmacokinetics Study
A Phase 1 Open-Label, Multicenter, Single and Multiple Ascending Dose Study to Evaluate Pharmacokinetics, Safety, and Tolerability of Lurasidone in Subjects 6 to 17 Years Old With Schizophrenia Spectrum, Bipolar Spectrum, Autistic Spectrum Disorder, or Other Psychiatric Disorders
Status: Enrolling
Updated:  3/10/2016
Segal Institute for Clinical Research
mi
from
Ft. Lauderdale, FL
Lurasidone Pediatric Pharmacokinetics Study
A Phase 1 Open-Label, Multicenter, Single and Multiple Ascending Dose Study to Evaluate Pharmacokinetics, Safety, and Tolerability of Lurasidone in Subjects 6 to 17 Years Old With Schizophrenia Spectrum, Bipolar Spectrum, Autistic Spectrum Disorder, or Other Psychiatric Disorders
Status: Enrolling
Updated: 3/10/2016
Segal Institute for Clinical Research
mi
from
Ft. Lauderdale, FL
Click here to add this to my saved trials
Lurasidone Pediatric Pharmacokinetics Study
A Phase 1 Open-Label, Multicenter, Single and Multiple Ascending Dose Study to Evaluate Pharmacokinetics, Safety, and Tolerability of Lurasidone in Subjects 6 to 17 Years Old With Schizophrenia Spectrum, Bipolar Spectrum, Autistic Spectrum Disorder, or Other Psychiatric Disorders
Status: Enrolling
Updated:  3/10/2016
Miami Children's Hospital
mi
from
South Miami, FL
Lurasidone Pediatric Pharmacokinetics Study
A Phase 1 Open-Label, Multicenter, Single and Multiple Ascending Dose Study to Evaluate Pharmacokinetics, Safety, and Tolerability of Lurasidone in Subjects 6 to 17 Years Old With Schizophrenia Spectrum, Bipolar Spectrum, Autistic Spectrum Disorder, or Other Psychiatric Disorders
Status: Enrolling
Updated: 3/10/2016
Miami Children's Hospital
mi
from
South Miami, FL
Click here to add this to my saved trials
Lurasidone Pediatric Pharmacokinetics Study
A Phase 1 Open-Label, Multicenter, Single and Multiple Ascending Dose Study to Evaluate Pharmacokinetics, Safety, and Tolerability of Lurasidone in Subjects 6 to 17 Years Old With Schizophrenia Spectrum, Bipolar Spectrum, Autistic Spectrum Disorder, or Other Psychiatric Disorders
Status: Enrolling
Updated:  3/10/2016
University Hospitals at Case Medical Center
mi
from
Cleveland, OH
Lurasidone Pediatric Pharmacokinetics Study
A Phase 1 Open-Label, Multicenter, Single and Multiple Ascending Dose Study to Evaluate Pharmacokinetics, Safety, and Tolerability of Lurasidone in Subjects 6 to 17 Years Old With Schizophrenia Spectrum, Bipolar Spectrum, Autistic Spectrum Disorder, or Other Psychiatric Disorders
Status: Enrolling
Updated: 3/10/2016
University Hospitals at Case Medical Center
mi
from
Cleveland, OH
Click here to add this to my saved trials
Effect of Music on Attention and Prospective Memory in Hepatic Encephalopathy
Effect of Music on Attention and Prospective Memory in Hepatic Encephalopathy
Status: Enrolling
Updated:  3/10/2016
NYU Medical Center
mi
from
New York, NY
Effect of Music on Attention and Prospective Memory in Hepatic Encephalopathy
Effect of Music on Attention and Prospective Memory in Hepatic Encephalopathy
Status: Enrolling
Updated: 3/10/2016
NYU Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
A Study To Assess the Effects Of PF-04457845 On BOLD fMRI In Subjects With Post Traumatic Stress Disorder
A Randomized, Double Blind, Placebo Controlled, Parallel Group Phase 2 Study To Assess Effects Of Pf 04457845 On Bold Functional Mri In Subjects With Ptsd
Status: Enrolling
Updated:  3/10/2016
NYU School of Medicine
mi
from
New York, NY
A Study To Assess the Effects Of PF-04457845 On BOLD fMRI In Subjects With Post Traumatic Stress Disorder
A Randomized, Double Blind, Placebo Controlled, Parallel Group Phase 2 Study To Assess Effects Of Pf 04457845 On Bold Functional Mri In Subjects With Ptsd
Status: Enrolling
Updated: 3/10/2016
NYU School of Medicine
mi
from
New York, NY
Click here to add this to my saved trials
A Study To Assess the Effects Of PF-04457845 On BOLD fMRI In Subjects With Post Traumatic Stress Disorder
A Randomized, Double Blind, Placebo Controlled, Parallel Group Phase 2 Study To Assess Effects Of Pf 04457845 On Bold Functional Mri In Subjects With Ptsd
Status: Enrolling
Updated:  3/10/2016
Clinical and Translational Science Institute (CTSI)
mi
from
New York, NY
A Study To Assess the Effects Of PF-04457845 On BOLD fMRI In Subjects With Post Traumatic Stress Disorder
A Randomized, Double Blind, Placebo Controlled, Parallel Group Phase 2 Study To Assess Effects Of Pf 04457845 On Bold Functional Mri In Subjects With Ptsd
Status: Enrolling
Updated: 3/10/2016
Clinical and Translational Science Institute (CTSI)
mi
from
New York, NY
Click here to add this to my saved trials
A Study To Assess the Effects Of PF-04457845 On BOLD fMRI In Subjects With Post Traumatic Stress Disorder
A Randomized, Double Blind, Placebo Controlled, Parallel Group Phase 2 Study To Assess Effects Of Pf 04457845 On Bold Functional Mri In Subjects With Ptsd
Status: Enrolling
Updated:  3/10/2016
NYU CTSI Research Pharmacy (Drug Shipment Address)
mi
from
New York, NY
A Study To Assess the Effects Of PF-04457845 On BOLD fMRI In Subjects With Post Traumatic Stress Disorder
A Randomized, Double Blind, Placebo Controlled, Parallel Group Phase 2 Study To Assess Effects Of Pf 04457845 On Bold Functional Mri In Subjects With Ptsd
Status: Enrolling
Updated: 3/10/2016
NYU CTSI Research Pharmacy (Drug Shipment Address)
mi
from
New York, NY
Click here to add this to my saved trials
Generalized Anxiety Disorder Proof of Concept Efficacy and Safety Study of SEP-225441 (Eszopiclone) In GAD Subjects
A Double Blind, Randomized, Placebo Controlled, Multicenter Study Examining the Efficacy and Safety of SEP-225441 in Subjects With Generalized Anxiety Disorder.
Status: Enrolling
Updated:  3/10/2016
Birmingham Psychiatry Pharaceutical Studies, Inc.
mi
from
Birmingham, AL
Generalized Anxiety Disorder Proof of Concept Efficacy and Safety Study of SEP-225441 (Eszopiclone) In GAD Subjects
A Double Blind, Randomized, Placebo Controlled, Multicenter Study Examining the Efficacy and Safety of SEP-225441 in Subjects With Generalized Anxiety Disorder.
Status: Enrolling
Updated: 3/10/2016
Birmingham Psychiatry Pharaceutical Studies, Inc.
mi
from
Birmingham, AL
Click here to add this to my saved trials
Generalized Anxiety Disorder Proof of Concept Efficacy and Safety Study of SEP-225441 (Eszopiclone) In GAD Subjects
A Double Blind, Randomized, Placebo Controlled, Multicenter Study Examining the Efficacy and Safety of SEP-225441 in Subjects With Generalized Anxiety Disorder.
Status: Enrolling
Updated:  3/10/2016
Clinical Research Facility
mi
from
Arcadia, CA
Generalized Anxiety Disorder Proof of Concept Efficacy and Safety Study of SEP-225441 (Eszopiclone) In GAD Subjects
A Double Blind, Randomized, Placebo Controlled, Multicenter Study Examining the Efficacy and Safety of SEP-225441 in Subjects With Generalized Anxiety Disorder.
Status: Enrolling
Updated: 3/10/2016
Clinical Research Facility
mi
from
Arcadia, CA
Click here to add this to my saved trials
Generalized Anxiety Disorder Proof of Concept Efficacy and Safety Study of SEP-225441 (Eszopiclone) In GAD Subjects
A Double Blind, Randomized, Placebo Controlled, Multicenter Study Examining the Efficacy and Safety of SEP-225441 in Subjects With Generalized Anxiety Disorder.
Status: Enrolling
Updated:  3/10/2016
Southwestern Research
mi
from
Beverly Hills, CA
Generalized Anxiety Disorder Proof of Concept Efficacy and Safety Study of SEP-225441 (Eszopiclone) In GAD Subjects
A Double Blind, Randomized, Placebo Controlled, Multicenter Study Examining the Efficacy and Safety of SEP-225441 in Subjects With Generalized Anxiety Disorder.
Status: Enrolling
Updated: 3/10/2016
Southwestern Research
mi
from
Beverly Hills, CA
Click here to add this to my saved trials
Generalized Anxiety Disorder Proof of Concept Efficacy and Safety Study of SEP-225441 (Eszopiclone) In GAD Subjects
A Double Blind, Randomized, Placebo Controlled, Multicenter Study Examining the Efficacy and Safety of SEP-225441 in Subjects With Generalized Anxiety Disorder.
Status: Enrolling
Updated:  3/10/2016
Southwestern Research, Inc.
mi
from
Burbank, CA
Generalized Anxiety Disorder Proof of Concept Efficacy and Safety Study of SEP-225441 (Eszopiclone) In GAD Subjects
A Double Blind, Randomized, Placebo Controlled, Multicenter Study Examining the Efficacy and Safety of SEP-225441 in Subjects With Generalized Anxiety Disorder.
Status: Enrolling
Updated: 3/10/2016
Southwestern Research, Inc.
mi
from
Burbank, CA
Click here to add this to my saved trials
Generalized Anxiety Disorder Proof of Concept Efficacy and Safety Study of SEP-225441 (Eszopiclone) In GAD Subjects
A Double Blind, Randomized, Placebo Controlled, Multicenter Study Examining the Efficacy and Safety of SEP-225441 in Subjects With Generalized Anxiety Disorder.
Status: Enrolling
Updated:  3/10/2016
California Clinical Trials Medical Group
mi
from
Glendale, CA
Generalized Anxiety Disorder Proof of Concept Efficacy and Safety Study of SEP-225441 (Eszopiclone) In GAD Subjects
A Double Blind, Randomized, Placebo Controlled, Multicenter Study Examining the Efficacy and Safety of SEP-225441 in Subjects With Generalized Anxiety Disorder.
Status: Enrolling
Updated: 3/10/2016
California Clinical Trials Medical Group
mi
from
Glendale, CA
Click here to add this to my saved trials